Loading…
Loading…
CNC does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CNC and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CNC and 80,000+ other tickers.
See exactly how CNC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CNC and 80,000+ other tickers.
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs…
Cavendish PLC (AIM:CAV) has raised its price target for Concurrent Technologies (AIM:CNC) to 302p from 256p after the embedded computing company reported record first-half results. The broker maintained its 'buy' rating on the AIM-listed company, whose shares it said now traded at 39.1 times forecast earnings for the current financial year.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors target stocks that have been on a bullish run. Stocks like PRAA, CNC, BILL and PARR are seeing price strength, and the momentum is likely to continue.
Rising employer healthcare costs could boost Marsh's consulting demand and create growth avenues for UnitedHealth and Centene through cost-control solutions.
CNC, VLO, and MNDY it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 3rd, 2026.